Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 429

1.

Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.

Schwoebel V, Chiang CY, Trébucq A, Piubello A, Aït-Khaled N, Koura KG, Heldal E, Van Deun A, Rieder HL.

Int J Tuberc Lung Dis. 2019 May 1;23(5):619-624. doi: 10.5588/ijtld.18.0798.

PMID:
31097072
2.

Reflections on the end TB strategy.

Rieder HL.

Indian J Tuberc. 2019 Jan;66(1):167-169. doi: 10.1016/j.ijtb.2019.02.003. Epub 2019 Feb 26. Review. No abstract available.

PMID:
30878063
3.

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.

Stratmann JA, von Rose AB, Koschade S, Wendelin K, Köhler F, Heinsch M, Schiller K, Haferlach C, Wattad M, Rieder H, Serve H, Gökbuget N, Steffen B.

Ann Hematol. 2019 Mar;98(3):647-656. doi: 10.1007/s00277-018-03590-x. Epub 2019 Jan 6. Review.

PMID:
30613837
4.

Sputum smear microscopy in the Xpert® MTB/RIF era.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):12-18. doi: 10.5588/ijtld.18.0553. Epub 2018 Dec 19.

PMID:
30567624
5.

Coupling of urban energy balance model with 3-D radiation model to derive human thermal (dis)comfort.

Oswald SM, Revesz M, Trimmel H, Weihs P, Zamini S, Schneider A, Peyerl M, Krispel S, Rieder HE, Mursch-Radlgruber E, Lindberg F.

Int J Biometeorol. 2019 Jun;63(6):711-722. doi: 10.1007/s00484-018-1642-z. Epub 2018 Dec 5.

PMID:
30519956
6.

Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.

Olaru ID, Albert H, Zallet J, Werner UE, Ahmed N, Rieder HL, Salfinger M, Kranzer K.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):309-320. doi: 10.5588/ijtld.17.0629.

PMID:
29471910
7.

Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.

Van Deun A, Decroo T, Piubello A, de Jong BC, Lynen L, Rieder HL.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):239-245. doi: 10.5588/ijtld.17.0660. Review.

PMID:
29471899
8.

Should gatifloxacin be included in the model list of essential medicines?

Chiang CY, Trébucq A, Piubello A, Rieder HL, Van Deun A.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702329. doi: 10.1183/13993003.02329-2017. Print 2018 Feb. No abstract available.

PMID:
29437946
9.

Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.

Trébucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, Hassane S, Souleymane B, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Cirillo DM, Koura KG, Rieder HL.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):17-25. doi: 10.5588/ijtld.17.0498. Epub 2017 Nov 17.

PMID:
29149917
10.

Informative, large cohorts of meningeal tuberculosis.

Rieder HL.

Indian J Tuberc. 2017 Oct;64(4):241-242. doi: 10.1016/j.ijtb.2017.07.001. Epub 2017 Jul 15. No abstract available.

PMID:
28941845
11.

Winter storm intensity, hazards, and property losses in the New York tristate area.

Shimkus CE, Ting M, Booth JF, Adamo SB, Madajewicz M, Kushnir Y, Rieder HE.

Ann N Y Acad Sci. 2017 Jul;1400(1):65-80. doi: 10.1111/nyas.13396. Epub 2017 Jul 17.

PMID:
28715602
12.

Gastric aspiration: routine use for diagnosis of pulmonary tuberculosis patients unable to expectorate sputum.

Kim SJ, Rieder HL.

Public Health Action. 2017 Jun 21;7(2):82. doi: 10.5588/pha.17.0042. No abstract available.

13.

Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.

Heldal E, Van Deun A, Chiang CY, Rieder HL.

Eur Respir J. 2017 Jun 1;49(6). pii: 1700228. doi: 10.1183/13993003.00228-2017. Print 2017 Jun. No abstract available.

14.

Behind the great walls.

Schoch OD, Rieder HL.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):601. doi: 10.5588/ijtld.17.0175. No abstract available.

PMID:
28482952
15.

Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.

Rieder HL, Van Deun A.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):123-124. doi: 10.5588/ijtld.16.0619. No abstract available.

PMID:
28157478
16.

The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors.

Hoffmann MJ, Koutsogiannouli E, Skowron MA, Pinkerneil M, Niegisch G, Brandt A, Stepanow S, Rieder H, Schulz WA.

Bladder Cancer. 2016 Oct 27;2(4):449-463. doi: 10.3233/BLC-160065.

17.

Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.

Zürcher K, Zwahlen M, Ballif M, Rieder HL, Egger M, Fenner L.

PLoS One. 2016 Oct 5;11(10):e0162575. doi: 10.1371/journal.pone.0162575. eCollection 2016.

18.

Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis.

Chiang CY, Van Deun A, Rieder HL.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1143-7. doi: 10.5588/ijtld.15.0884.

PMID:
27510237
19.

Challenges in the diagnosis of extrapulmonary tuberculosis.

Rieder HL.

Indian J Tuberc. 2016 Apr;63(2):67-8. doi: 10.1016/j.ijtb.2016.05.013. Epub 2016 Jun 16. No abstract available.

PMID:
27451811
20.

Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.

Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L.

J Clin Microbiol. 2016 Jul;54(7):1862-1870. doi: 10.1128/JCM.00126-16. Epub 2016 May 18.

21.

The King's Evil and the Royal Touch: the medical history of scrofula.

Murray JF, Rieder HL, Finley-Croswhite A.

Int J Tuberc Lung Dis. 2016 Jun;20(6):713-6. doi: 10.5588/ijtld.16.0229. No abstract available.

PMID:
27155172
22.

Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950.

Zürcher K, Ballif M, Zwahlen M, Rieder HL, Egger M, Fenner L.

PLoS One. 2016 Feb 16;11(2):e0149195. doi: 10.1371/journal.pone.0149195. eCollection 2016.

23.

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.

Lorenz S, Barøy T, Sun J, Nome T, Vodák D, Bryne JC, Håkelien AM, Fernandez-Cuesta L, Möhlendick B, Rieder H, Szuhai K, Zaikova O, Ahlquist TC, Thomassen GO, Skotheim RI, Lothe RA, Tarpey PS, Campbell P, Flanagan A, Myklebost O, Meza-Zepeda LA.

Oncotarget. 2016 Feb 2;7(5):5273-88. doi: 10.18632/oncotarget.6567.

24.

Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.

Rigouts L, Coeck N, Gumusboga M, de Rijk WB, Aung KJ, Hossain MA, Fissette K, Rieder HL, Meehan CJ, de Jong BC, Van Deun A.

J Antimicrob Chemother. 2016 Feb;71(2):314-23. doi: 10.1093/jac/dkv360. Epub 2015 Nov 24.

25.

Do Instructional Videos on Sputum Submission Result in Increased Tuberculosis Case Detection? A Randomized Controlled Trial.

Mhalu G, Hella J, Doulla B, Mhimbira F, Mtutu H, Hiza H, Sasamalo M, Rutaihwa L, Rieder HL, Seimon T, Mutayoba B, Weiss MG, Fenner L.

PLoS One. 2015 Sep 29;10(9):e0138413. doi: 10.1371/journal.pone.0138413. eCollection 2015.

26.

Climate variability modulates western US ozone air quality in spring via deep stratospheric intrusions.

Lin M, Fiore AM, Horowitz LW, Langford AO, Oltmans SJ, Tarasick D, Rieder HE.

Nat Commun. 2015 May 12;6:7105. doi: 10.1038/ncomms8105.

27.

High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.

Kuaban C, Noeske J, Rieder HL, Aït-Khaled N, Abena Foe JL, Trébucq A.

Int J Tuberc Lung Dis. 2015 May;19(5):517-24. doi: 10.5588/ijtld.14.0535.

PMID:
25868018
28.

Jean-Antoine Villemin: ending an Alpine divide.

Rieder HL.

Int J Tuberc Lung Dis. 2015 Mar;19(3):253. doi: 10.5588/ijtld.15.0012. No abstract available.

PMID:
25686126
29.

Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing.

Stucki D, Ballif M, Bodmer T, Coscolla M, Maurer AM, Droz S, Butz C, Borrell S, Längle C, Feldmann J, Furrer H, Mordasini C, Helbling P, Rieder HL, Egger M, Gagneux S, Fenner L.

J Infect Dis. 2015 Apr 15;211(8):1306-16. doi: 10.1093/infdis/jiu601. Epub 2014 Oct 30.

30.

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.

Hoelzer D, Walewski J, Döhner H, Viardot A, Hiddemann W, Spiekermann K, Serve H, Dührsen U, Hüttmann A, Thiel E, Dengler J, Kneba M, Schaich M, Schmidt-Wolf IG, Beck J, Hertenstein B, Reichle A, Domanska-Czyz K, Fietkau R, Horst HA, Rieder H, Schwartz S, Burmeister T, Gökbuget N; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia.

Blood. 2014 Dec 18;124(26):3870-9. doi: 10.1182/blood-2014-03-563627. Epub 2014 Oct 30.

31.

Of drug susceptibility test results, gold standards, and test operating characteristics.

Rieder HL.

Indian J Tuberc. 2014 Jul;61(3):181-2. No abstract available.

PMID:
25241563
32.

Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.

Aung KJ, Van Deun A, Declercq E, Sarker MR, Das PK, Hossain MA, Rieder HL.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1180-7. doi: 10.5588/ijtld.14.0100.

PMID:
25216831
33.

Hidden mutations in Cornelia de Lange syndrome limitations of sanger sequencing in molecular diagnostics.

Braunholz D, Obieglo C, Parenti I, Pozojevic J, Eckhold J, Reiz B, Braenne I, Wendt KS, Watrin E, Vodopiutz J, Rieder H, Gillessen-Kaesbach G, Kaiser FJ.

Hum Mutat. 2015 Jan;36(1):26-9. doi: 10.1002/humu.22685. Epub 2014 Dec 2. Erratum in: Hum Mutat. 2015 Feb;36(2):279-80.

PMID:
25196272
34.

A new workflow for whole-genome sequencing of single human cells.

Binder V, Bartenhagen C, Okpanyi V, Gombert M, Moehlendick B, Behrens B, Klein HU, Rieder H, Ida Krell PF, Dugas M, Stoecklein NH, Borkhardt A.

Hum Mutat. 2014 Oct;35(10):1260-70. doi: 10.1002/humu.22625. Epub 2014 Aug 18.

PMID:
25066732
35.

Molecular epidemiology of tuberculosis in Cambodian children.

Schopfer K, Rieder HL, Steinlin-Schopfer JF, van Soolingen D, Bodmer T, Chantana Y, Studer P, Laurent D, Zwahlen M, Richner B.

Epidemiol Infect. 2015 Apr;143(5):910-21. doi: 10.1017/S0950268814001769. Epub 2014 Jul 22.

PMID:
25050615
36.

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.

Weilandt M, Koch A, Rieder H, Deenen R, Schwender H, Niegisch G, Schulz WA.

Cancer Genomics Proteomics. 2014 May-Jun;11(3):141-53.

PMID:
24969694
37.

Ninety years after The Magic Mountain: world literature inspired by a misdiagnosis, a tribute to Christian Virchow.

Rieder HL.

Int J Tuberc Lung Dis. 2014 Jul;18(7):761-2. doi: 10.5588/ijtld.13.0183. No abstract available.

PMID:
24902548
38.

The dynamics of tuberculosis epidemiology.

Rieder HL.

Indian J Tuberc. 2014 Jan;61(1):19-29. Review.

PMID:
24640341
39.

Serial screening for latent tuberculosis infection in healthcare workers in low-risk settings.

Zellweger JP, Rieder HL.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):3-4. doi: 10.1164/rccm.201311-2062ED. No abstract available.

PMID:
24381985
40.

The relationship between organized violence, family violence and mental health: findings from a community-based survey in Muhanga, Southern Rwanda.

Rieder H, Elbert T.

Eur J Psychotraumatol. 2013 Nov 13;4. doi: 10.3402/ejpt.v4i0.21329. eCollection 2013.

41.

The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis.

Schopfer K, Rieder HL, Bodmer T, Steinlin-Schopfer JF, Chantana Y, Studer P, Laurent D, Richner B.

Eur J Pediatr. 2014 Mar;173(3):331-6. doi: 10.1007/s00431-013-2161-x. Epub 2013 Sep 25.

PMID:
24065457
42.
43.

Efficient, quality-assured data capture in operational research through innovative use of open-access technology.

Kumar AM, Naik B, Guddemane DK, Bhat P, Wilson N, Sreenivas AN, Lauritsen JM, Rieder HL.

Public Health Action. 2013 Mar 21;3(1):60-2. doi: 10.5588/pha.13.0004.

44.

HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis.

Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder HL, Zwahlen M, Hoffmann M, Bernasconi E, Cavassini M, Calmy A, Dolina M, Frei R, Janssens JP, Borrell S, Stucki D, Schrenzel J, Böttger EC, Gagneux S; Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups.

PLoS Genet. 2013;9(3):e1003318. doi: 10.1371/journal.pgen.1003318. Epub 2013 Mar 7.

45.

The enigma of extra-pulmonary tuberculosis.

Rieder HL.

Int J Tuberc Lung Dis. 2013 Feb;17(2):144. doi: 10.5588/ijtld.12.0972. No abstract available.

PMID:
23317947
46.

Changes in body weight and tuberculosis treatment outcome in Viet Nam.

Hoa NB, Lauritsen JM, Rieder HL.

Int J Tuberc Lung Dis. 2013 Jan;17(1):61-6. doi: 10.5588/ijtld.12.0369. Epub 2012 Nov 9.

PMID:
23146565
47.

Of tangible benefits that remain unexplained: the Papworth village movement to take care of tuberculous families.

Rieder HL.

Am J Respir Crit Care Med. 2012 Sep 1;186(5):397-8. doi: 10.1164/rccm.201207-1183ED. No abstract available.

PMID:
22942343
48.

Involvement of the MLL gene in adult T-lymphoblastic leukemia.

Türkmen S, Timmermann B, Bartels G, Gröger D, Meyer C, Schwartz S, Haferlach C, Rieder H, Gökbuget N, Hoelzer D, Marschalek R, Burmeister T.

Genes Chromosomes Cancer. 2012 Dec;51(12):1114-24. doi: 10.1002/gcc.21996. Epub 2012 Aug 25.

PMID:
22927255
49.

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Koch A, Hatina J, Rieder H, Seifert HH, Huckenbeck W, Jankowiak F, Florl AR, Stoehr R, Schulz WA.

Cell Oncol (Dordr). 2012 Aug;35(4):243-57. doi: 10.1007/s13402-012-0082-8. Epub 2012 Jun 6.

PMID:
22669776
50.

In reply to 'Should Xpert® MTB/RIF be rolled out in low-income countries?' [Correspondence].

Trébucq A, Harries AD, Rieder HL.

Int J Tuberc Lung Dis. 2012 May 1;16(5):703-704. doi: 10.5588/ijtld.12.0034-2. No abstract available.

PMID:
29070251

Supplemental Content

Loading ...
Support Center